Invokamet (canagliflozin and metformin hydrochloride) Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
CONTRAINDICATIONS
History of a serious hypersensitivity reaction to canagliflozin or metformin, such as anaphylaxis or...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Anaphylactic Shock | Canagliflozin | Drugs & Pharmacology | Fortamet | Invokana | Metformin